Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine.The vaccine uses the same messenger RNA technology as Pfizer’s…